Skip to main content
. Author manuscript; available in PMC: 2012 Mar 29.
Published in final edited form as: Mt Sinai J Med. 2011 Jul-Aug;78(4):596–612. doi: 10.1002/msj.20279

Table 7.

Pharmacologic Management of Behavioral Symptoms of Dementia25,26,45.

Starting Dose (mg) Usual/Maximal Dose (mg) Comments/Side Effects
Antipsychotics
 Aripiprazole 2 7–12 QD Weight neutral, metabolic abnormalities
 Olanzapine 2.5 5–10 QD to BID Weight gain, sedation, metabolic abnormalities
 Quetiapine 12.5 50–200 QD to BID Orthostasis, sedation, metabolic abnormalities
 Risperidone 0.25 0.5–1.5 QD to BID Weight gain, sedation, hyperprolactinemia, metabolic abnormalities. Risk of EPS at higher doses.
 Ziprasidone 20 60–80 QD to BID Less risk of metabolic abnormalities, greater risk of QT prolongation
Other medications
 Trazodone 25 QD to BID 50–250 daily Can use q4h or prior to usual sundowning, or at HS, being careful about maximal dosing. Sedation, orthostasis, rare cardiac conduction abnormalities.
SSRIs See Table 5 for dosing and considerations
 Lamotrigine 25 daily 50–400 daily Slow titration; observe for Stevens-Johnson syndrome
 Gabapentin 100 QD to BID Up to 1800 in divided doses Renally excreted
Memantine or cholinesterase inhibitors Usual dosing

Abbreviations: BID, 2 times a day; EPS, extrapyramidal symptoms; HS, at bedtime; q4h, every 4 hours; QD, every day; QT, QT interval; SSRI, selective serotonin reuptake inhibitor.